Greece Hospital Anti-infectives Market: By Product (Antibacterial, Antifungals, Antivirals), By Disease Type (Bloodstream Infections, Urinary Tract Infections, Surgical Site Infections, Respiratory Infections, Gastrointestinal Infections, others), By Microorganism (Bacteria, Viruses, Fungi, Others), By Route of Administration (Oral, Topical, Parenteral, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others), and Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

1. Executive Summary
2. Greece Hospital Anti-infectives Market Introduction
2.1. Greece Hospital Anti-infectives Market – Taxonomy
2.2. Greece Hospital Anti-infectives Market –Definitions
2.2.1. By Product
2.2.2. By Disease Type
2.2.3. By Microorganism
2.2.4. By Route of Administration
2.2.5. By Distribution Channel
3. Greece Hospital Anti-infectives Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Greece Hospital Anti-infectives Market Dynamic Factors - Impact Analysis
3.6. Impact of COVID 19 on The Market
4. Greece Hospital Anti-infectives Market Forecast, By Product, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million)
4.1. Antibacterial
4.1.1. ?-Lactams
4.1.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
4.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.1.1.3. Market Opportunity Analysis
4.1.2. Tetracycline
4.1.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
4.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.1.2.3. Market Opportunity Analysis
4.1.3. Quinolones
4.1.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
4.1.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.1.3.3. Market Opportunity Analysis
4.1.4. Macrolides
4.1.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
4.1.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.1.4.3. Market Opportunity Analysis
4.1.5. Sulphonamide
4.1.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
4.1.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.1.5.3. Market Opportunity Analysis
4.1.6. Others
4.1.6.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
4.1.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.1.6.3. Market Opportunity Analysis
4.2.  Antifungals
4.2.1. Azoles
4.2.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
4.2.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.2.1.3. Market Opportunity Analysis
4.2.2. Echinocandins
4.2.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
4.2.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.2.2.3. Market Opportunity Analysis
4.2.3. Polyenes
4.2.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
4.2.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.2.3.3. Market Opportunity Analysis
4.2.4. Others
4.2.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
4.2.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.2.4.3. Market Opportunity Analysis ?-Lactams
4.3. Antivirals
4.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million)
4.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
4.3.3. Market Opportunity Analysis
5. Greece Hospital Anti-infectives Market Forecast, By Disease Type, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million)
5.1. Bloodstream Infections
5.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Urinary Tract Infections
5.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Surgical Site Infections
5.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Respiratory Infections
5.4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Gastrointestinal Infections
5.5.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
5.6. Others
5.6.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million)
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.6.3. Market Opportunity Analysis
6. Greece Hospital Anti-infectives Market Forecast, By Microorganism, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million)
6.1. Bacteria
6.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Virus
6.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Fungi
6.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Others
6.4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
7. Greece Hospital Anti-infectives Market Forecast, By Route of Administration, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million)
7.1. Oral
7.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Topical
7.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Parenteral
7.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Others
7.4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
8. Greece Hospital Anti-infectives Market Forecast, By Distribution Channel, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million)
8.1. Hospital Pharmacy
8.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Retail Pharmacy
8.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Others
8.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
9. Competition Landscape 
9.1. Strategic Dashboard of Top Market Players
9.2. Company Profiles (Introduction, Financial Analysis, Product Type Offerings, Key Developments, Strategies, and SWOT Analysis)
9.2.1. GlaxoSmithKline plc.
9.2.2. Pfizer, Inc
9.2.3. Bayer AG
9.2.4. Sanofi
9.2.5. Merck & Co., Inc.
9.2.6. Bristol-Myers Squibb Company
9.2.7. Abbott
9.2.8. Novartis AG
9.2.9. Johnson & Johnson Services, Inc
9.2.10. Astellas Pharma Inc
10. Research Methodology
11. Key Assumptions and Acronyms

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

  • GlaxoSmithKline plc.
  • Pfizer, Inc
  • Bayer AG
  • Sanofi
  • Merck & Co., Inc.
  • Bristol-Myers Squibb Company
  • Abbott
  • Novartis AG
  • Johnson & Johnson Services, Inc
  • Astellas Pharma Inc

Adjacent Markets

Eosinophilia Market
Dyspepsia Market
Disseminated Intravascular Coagulation Market
Alpha Thalassemia Market
Allergic Rhinitis Market
Histamine Analogs Market